Tag: Insulet
In brief: Appeals transition, Insulet raise, Heartland keynotes
May 8, 2026HME News Staff
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) has announced that, effective May 8, 2026, Chags Health Information Technology LLC (C-HIT) will no longer handle DMEPOS appeals and rebuttals. Responsibility for processing these submissions will transition to the National Provider Enrollment (NPE) DMEPOS contractors.
The two NPE contractors are: Palmetto GBA for the western half of the country (NPEC West) and Novitas for the eastern half (NPEC East).
What this...
Insulet sees momentum, raises outlook
May 7, 2026HME News Staff
ACTON, Mass. – Insulet reported revenue of $761.7 million for the first quarter of 2026, an increase of 33.9% over the prior year. Total Omnipod revenue was $758.4 million, up 36.9%. Of that, U.S. Omnipod revenue was $515.6 million and international Omnipod revenue was $242.9 million.
“We started the year strong, delivering continued growth momentum and robust operating margin expansion in the first quarter,” said Ashley McEvoy, president and CEO. “Our team executed on...
In brief: New York’s John Quinlan named Van Miller Homecare Champion
February 20, 2026HME News Staff
WASHINGTON – AAHomecare has announced that John Quinlan is this year’s Van Miller Homecare Champion, recognizing three decades of extraordinary leadership, generosity, spirit of caring and service to the HME community.
Quinn, president and CEO of Quinlan's Pharmacy and Medical Equipment, also has held industry leadership roles, including Chair of the AAHomecare State Leaders Council, service on AAHomecare’s Executive...
Insulet’s Omnipod continues to deliver
February 19, 2026HME News Staff
ACTON, Mass. – Insulet Corporation reported revenue of $783.8 million for the fourth quarter of 2025, an increase of 31% over the same period a year prior and ahead of the company’s guidance in the 25% to 28% range.
Of that, U.S. Omnipod revenue was $567.8 million and international Omnipod revenue was $214 million.
For the full year, Insulet reported revenue of $2.7 billion, an increase of 30.7%, over...
In brief: Medicare comparison legislation, Omnipod expansion, Owlet partnership
February 18, 2026HME News Staff
WASHINGTON — Senator Tim Scott, R-S.C., has introduced the Apples to Apples Comparison Act of 2026, which seeks to require the Centers for Medicare and Medicaid Services (CMS) to provide seniors with clear, comparable data when choosing between Medicare Advantage (MA) and traditional fee-for-service coverage. By giving seniors accurate cost and coverage information, the legislation empowers them to choose the plan that best meets their health care needs. “Seniors...
Insulet’s Omnipod 5 available in Middle East
February 17, 2026HME News Staff
ACTON, Mass. – Insulet’s Omnipod 5 Automated Insulin Delivery (AID) System is now available in the Middle East – including Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates (UAE). “We’re proud to bring Omnipod 5 to a region where the unmet need is great,” said Pat Crannell, senior vice president and international general manager. “These launches build on our significant momentum as we continue to transform the lives of people...
In brief: Aetna revisits CPAP code change, NHIA pushes bills, Insulet campaigns for diabetes
November 12, 2025HME News Staff
HARTFORD, Conn. - Aetna is once again trying to require adherence codes G8851, G8854 and G8855 for reimbursement for CPAP devices or supplies, the Midwest Association for Medical Equipment Services & Suppliers (MAMES) reports.
The insurer tried the same move earlier this year, but after the HME industry pushed back, saying providers can’t bill these codes, it pulled back the change.
In an October 2025 list of upcoming policy changes and reminders, however, Aetna states:
“Beginning...
Insulet sees 31% revenue jump
November 10, 2025HME News Staff
ACTON, Mass. – Insulet reported Omnipod revenue of $699.2 million for the third quarter of 2025, up 31% over the same quarter in 2024. Of that, U.S. Omnipod revenue was $497.1 million and International Omnipod revenue was $202.1 million. “We delivered strong third quarter results, a testament to our team’s exceptional performance and the transformative power of Omnipod 5 for people living with diabetes,” said Ashley McEvoy,...
Insulet launches workplace-focused campaign for Diabetes Awareness Month
November 10, 2025HME News Staff
ACTON, Mass. – Insulet has launched a new campaign, “The Day Diabetes Showed Up to Work,” in honor of Diabetes Awareness Month in November.
“Nearly 590 million people worldwide live with diabetes, and approximately 70% are of working age,” said Ashley McEvoy, president and CEO. “Yet too often their experience at work is shaped by misunderstanding, fear of disclosure and a lack of meaningful support. At Insulet, we’re proud...
Pump up the superpower: Insulet, Marvel launch comic hero with Type 1 diabetes
September 12, 2025Tracy Orzel
ACTON, Mass. – Strapping on an insulin pump may not always feel heroic, but Insulet and Marvel are changing that narrative with a new comic that puts a character with Type 1 diabetes at the center of the story.
“At Insulet, we know representation matters and it has a direct impact on how kids and teens embrace diabetes technology,” said Lucas Escobar, the company’s director of U.S. consumer marketing. “That belief drove us to collaborate with Marvel, one of...